CIK 0001819576
- Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851710962
- Phone
- +1 919-328-4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- 4 Planned sale Chief Business Officer sold 454 shares at $19.54 ($8,871)
- 4 Planned sale Chief Accounting Officer sold 1,063 shares at $19.54 ($20,771)
- 4 Planned sale Chief Medical Officer sold 2,526 shares at $14.54 ($36,728)
- 4 Planned sale General Counsel sold 7,836 shares at $14.28 ($111,898)
- 4 Planned sale Chief Medical Officer sold 5,327 shares at $14.28 ($76,070)
- 4 Planned sale Chief Commercial Officer sold 4,797 shares at $14.28 ($68,501)
- 4 Planned sale Chief Human Resource Officer sold 2,673 shares at $14.28 ($38,170)
- 4 Planned sale CFO and COO sold 11,580 shares at $14.28 ($165,362)
- 4 Planned sale Chief Executive Officer sold 20,252 shares at $14.28 ($289,199)
- 4 Planned sale Chief Executive Officer sold 20,252 shares at $14.28 ($289,199)
- 4 Planned sale Chief Accounting Officer sold 1,193 shares at $14.28 ($17,036)
- 4 Planned sale Chief Business Officer sold 2,576 shares at $14.28 ($36,785)
- 4 Grant or award Chief Human Resource Officer acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 18,396 shares (grant or award)
- 4 Grant or award Director acquired 18,396 shares (grant or award)
- 4 Grant or award Director acquired 18,396 shares (grant or award)
- 4 Grant or award Director acquired 18,396 shares (grant or award)
Page 8 of 21 · 410 filings